RMFCX | TQCRX | RMFCX / TQCRX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 23 years | 4 years | - |
Gain YTD | 4.836 | 5.064 | 95% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 50000 | 1% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 105B | 2.43B | 4,330% |
Annual Yield % from dividends | 1.69 | 2.35 | 72% |
Returns for 1 year | 11.03 | 10.23 | 108% |
Returns for 3 years | 19.69 | 16.32 | 121% |
Returns for 5 years | 41.75 | N/A | - |
Returns for 10 years | 64.83 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FBTIX | 30.38 | -0.05 | -0.16% |
Fidelity Advisor Biotechnology I | |||
CLSYX | 19.87 | -0.07 | -0.35% |
Columbia International Div Inc Inst3 | |||
LYRWX | 12.09 | -0.18 | -1.47% |
Lyrical International Value Equity Instl | |||
TIRTX | 28.64 | -0.68 | -2.32% |
Nuveen Large Cap Growth A | |||
DCGTX | 18.23 | -0.44 | -2.36% |
Jackson Square SMID-Cap Growth IS |